Feed TSNLF
TS

Tristel PLC TSNLF · OTC

$5.52 +0.00% (+$0.00)

Market cap
£197.2M
Enterprise value
£188.1M
P/E
24.6x
Forward P/E
21.2x
PEG
1.4x
P/S
3.8x
P/FCF
18.2x
EV/EBITDA
13.2x
ROIC
19.3%
Gross margin
76.9%
Net margin
15.6%
Dividend yield
3.41%
Payout ratio
84.1%
Net debt/EBITDA
-0.6x
Beta
0.35
Free float
98.3%

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Christopher Paul Lee

Employees

267

Headquarters

Snailwell

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

  • What speaks for it: Earnings per share grew by 19% a year over the last 3 years.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What speaks for it: Out of every 100 GBP of revenue, 16 GBP is left as net profit.
  • What speaks for it: It earns 19 GBP a year on every 100 GBP of invested capital.

Financial health

Can it carry its debt?

  • What speaks for it: It holds more cash than debt: £14.9M against £5.82M.

Capital and dividends

What does the company do with the money it earns?

  • What to watch: 84% of profit goes to the dividend, leaving little room to raise it.

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy